Q&A: Page 9
Exclusive interviews with industry leaders
-
Courtesy of Saniona
Saniona's CEO on why it takes a village to develop treatments for a rare disease
Saniona built its village by first hiring a head of patient advocacy.
Kim Ribbink • Feb. 8, 2022 -
Retrieved from Google image.
Gaining real-world results from a decentralized trial
Lark’s principal Investigator OraLee Branch hopes a DCT will lead the company to their true audience.
Kelly Bilodeau • Feb. 8, 2022 -
Courtesy of 23andMe
Why 23andMe's first solo clinical trial is a big deal
It's the first test for a compound developed with the help of the company's genetic data — and there could be plenty more to come.
Taren Grom • Feb. 7, 2022 -
Permission granted by Mary Harmon
PTC's vice president of patient relations outlines the importance of patient input in rare disease R&D
You can't know what matters to rare disease patients unless you ask them.
Kim Ribbink • Feb. 3, 2022 -
Permission granted by Peter Anastasiou
New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality
Read what Capsida CEO Peter Anastasiou has planned for his new role.
Taren Grom • Feb. 3, 2022 -
Retrieved from Rare Disease.org.
For the CEO of Travere, running a rare disease company is personal
To kick off Rare Disease month, we interview the CEO of Travere Therapeutics
Kim Ribbink • Feb. 1, 2022 -
Foghorn's CEO on why collaborations are key to unlocking precision medicine
With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.
Robin Robinson • Jan. 28, 2022 -
Courtesy of Sanofi
Sanofi's chief scientist on why 'this is the moment' for AI in Big Pharma
How a $5.2 billion AI investment is enabling the French pharma to accelerate drug development.
Meagan Parrish • Jan. 27, 2022 -
Justin Sullivan via Getty Images
With its wealth of patient data, Walgreens is looking to disrupt the clinical trial space
How the mega-pharmacy’s clinical trials officer is looking to capitalize on its deep well of patient data to create an interconnected healthcare system of the future.
Taren Grom • Jan. 26, 2022 -
[photo]. Retrieved from Ovid Therapeutics.
Ovid's CEO shares his vision for rare disease developments
Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.
Kim Ribbink • Jan. 10, 2022 -
Justin Sullivan/ via Getty Images
How the executive VP of HR at Incyte is tackling pharma's hiring woes
In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.
Meagan Parrish • Jan. 10, 2022 -
PharmaVoice Team/PharmaVoice
Last Word: PharmaVOICE The Next Frontier
With Industry Dive acquiring PharmaVOICE, Taren Grom, Editor of PharmaVOICE, sat down with Davide Savenije, Editor-in-Chief of Industry Dive, to discuss what’s coming in 2022, and what you, our community, can expect with the relaunch in January. PV: After 20-plus years as a print publica...
Davide Savenije • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Last Word
Six Keys to Beating the Odds and Achieving Startup Success Sharon Cunningham, Co-founder and CEO of Shorla Pharma, details the six steps she and her partner undertook to launch a successful biopharma company. PV: What was it like starting up Shorla Pharma? Cunningham: Starting your own c...
Sharon Cunningham • Nov. 16, 2020 -
PharmaVoice Team/PharmaVoice
Last Word
The Impact Of COVID-19 On The Workplace Laurie Cooke, President and CEO of the Healthcare Businesswomen’s Association (HBA), highlights some of the ways the pandemic is impacting companies and employees across the industry. PV: The HBA conducted a survey among its corporate partner co...
Laurie Cooke • Oct. 1, 2020 -
PharmaVoice Team/PharmaVoice
Last Word
Transforming the Practice of Medicine John Cox, CEO of Repertoire Immune Medicines — a clinical-stage immuno-therapy company — talks about unleashing the curative powers of the immune system to prevent and cure cancer, autoimmune, and infectious diseases. PV: Repertoire Therapeu...
John Cox • April 1, 2020
Previous
To find more content, use the "Topics" in the menu above.